SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (266)1/11/1999 9:31:00 AM
From: scaram(o)uche  Read Replies (2) | Respond to of 579
 
and the uglies continue..... thanks, Mike.

from today's SCI) release......

"Alzheimer's disease affects an estimated four million Americans, and
U.S. society currently spends at least $100 billion on Alzheimer's disease each year."



To: Mike McFarland who wrote (266)2/3/1999 4:23:00 PM
From: LLCF  Respond to of 579
 
<Cadus Announces Decision by U.S. Patent Office to Re-Examine Patent at Issue in Sibia Lawsuit>

Scrolling back through SIBI and NBIX as possible investments... interesting that SIBI was awarded about 40% of their market cap! Market yawns...

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News